M Di Nisio1,2, A Ponzano3,4, G M Tiboni3,4, M D Guglielmi5, A W S Rutjes6,7, E Porreca8. 1. Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. mdinisio@unich.it. 2. Department of Medicine and Ageing Sciences, University G. D'Annunzio, Via dei Vestini 15, 66100, Chieti-Pescara, Italy. mdinisio@unich.it. 3. Department of Medicine and Ageing Sciences, University G. D'Annunzio, Via dei Vestini 15, 66100, Chieti-Pescara, Italy. 4. Unit of Assisted Reproductive Technology, Ortona General Hospital, Ortona (Chieti), Italy. 5. Department of Internal Medicine, Ospedale SS. ma Annunziata, Chieti, Italy. 6. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. 7. Institute of Primary Health Care, University of Bern, Bern, Switzerland. 8. Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti, Italy.
Abstract
PURPOSE: Retrospective and cross-sectional studies suggested that non-O blood group may be associated with failures of in vitro fertilization (IVF), but data remain controversial. The aim of this observational cohort study was to prospectively evaluate the effect of non-O blood type on clinical outcomes of IVF. METHODS: Women < 40 years who underwent IVF and had ABO blood type recorded as part of the routine workup were eligible. The primary study outcome was live birth. Secondary outcomes included spontaneous abortion, positive pregnancy test, and clinical pregnancy. RESULTS: A total of 497 women with a mean age of 34.6 (standard deviation 3.2) years were included. The mean number of embryos transferred was 2.3 (standard deviation 0.6). The most common ABO blood types were O (n = 213, 42.9%) and A (n = 203, 40.8%), while 63 (12.7%) and 18 (3.6%) women had the B and AB blood types, respectively. Differences in live birth (21.8 vs. 24.3%, odds ratio [OR] 1.17; 95% confidence intervals [CI], 0.76 to 1.78), positive pregnancy test (37.9 vs. 36.6%, OR 0.96; 95% CI, 0.66 to 1.38), clinical pregnancy (35.1 vs. 33.8%, OR 0.95; 95% CI, 0.66 to 1.39), and spontaneous abortion (12.3 vs. 9.2%, OR 0.72; 95% CI, 0.41 to 1.29) between women with O and non-O blood type were not statistically significant. CONCLUSIONS: In a prospective cohort study, we confirmed the lack of a significant association between non-O blood type and clinical outcomes of IVF. Further studies are needed to clarify whether non-O blood group has any prognostic relevance in women undergoing IVF.
PURPOSE: Retrospective and cross-sectional studies suggested that non-O blood group may be associated with failures of in vitro fertilization (IVF), but data remain controversial. The aim of this observational cohort study was to prospectively evaluate the effect of non-O blood type on clinical outcomes of IVF. METHODS:Women < 40 years who underwent IVF and had ABO blood type recorded as part of the routine workup were eligible. The primary study outcome was live birth. Secondary outcomes included spontaneous abortion, positive pregnancy test, and clinical pregnancy. RESULTS: A total of 497 women with a mean age of 34.6 (standard deviation 3.2) years were included. The mean number of embryos transferred was 2.3 (standard deviation 0.6). The most common ABO blood types were O (n = 213, 42.9%) and A (n = 203, 40.8%), while 63 (12.7%) and 18 (3.6%) women had the B and AB blood types, respectively. Differences in live birth (21.8 vs. 24.3%, odds ratio [OR] 1.17; 95% confidence intervals [CI], 0.76 to 1.78), positive pregnancy test (37.9 vs. 36.6%, OR 0.96; 95% CI, 0.66 to 1.38), clinical pregnancy (35.1 vs. 33.8%, OR 0.95; 95% CI, 0.66 to 1.39), and spontaneous abortion (12.3 vs. 9.2%, OR 0.72; 95% CI, 0.41 to 1.29) between women with O and non-O blood type were not statistically significant. CONCLUSIONS: In a prospective cohort study, we confirmed the lack of a significant association between non-O blood type and clinical outcomes of IVF. Further studies are needed to clarify whether non-O blood group has any prognostic relevance in women undergoing IVF.
Authors: Marcello Di Nisio; Anne W S Rutjes; Noemi Ferrante; Gian Mario Tiboni; Franco Cuccurullo; Ettore Porreca Journal: Blood Date: 2011-06-24 Impact factor: 22.113
Authors: Francesco Dentali; Anna Paola Sironi; Walter Ageno; Sara Turato; Carlo Bonfanti; Francesco Frattini; Silvia Crestani; Massimo Franchini Journal: Semin Thromb Hemost Date: 2012-06-27 Impact factor: 4.180
Authors: T Ohira; M Cushman; M Y Tsai; Y Zhang; S R Heckbert; N A Zakai; W D Rosamond; A R Folsom Journal: J Thromb Haemost Date: 2007-04-09 Impact factor: 5.824
Authors: Matteo Candeloro; Marcello Di Nisio; Adalisa Ponzano; Gian Mario Tiboni; Nicola Potere; Marco Tana; Anne W S Rutjes; Ettore Porreca Journal: Front Endocrinol (Lausanne) Date: 2020-12-23 Impact factor: 5.555
Authors: Perry R Fleming; Makayla M Swygert; Coen Hasenkamp; Jessica Sterling; Ginny Cartee; Rebecca Russ-Sellers; Melanie Cozad; Renee J Chosed; William E Roudebush; Ann Blair Kennedy Journal: Res Involv Engagem Date: 2021-05-12